BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32800655)

  • 1. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
    Ko EM; Brensinger CM; Cory L; Giuntoli RL; Haggerty AF; Latif NA; Aviles D; Martin L; Morgan MA; Lin LL
    Gynecol Oncol; 2020 Nov; 159(2):394-401. PubMed ID: 32800655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
    van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
    Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
    Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
    Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
    Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity after adjuvant therapy for stage III uterine cancer.
    Chen LC; Huang Y; Hou JY; Khoury-Collado F; Melamed A; St Clair CM; Tergas AI; Hur C; Hillyer GC; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Dec; 159(3):737-743. PubMed ID: 33008633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
    Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
    Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis.
    Modh A; Ghanem AI; Burmeister C; Hanna RK; Elshaikh MA
    Int J Gynecol Cancer; 2018 Feb; 28(2):248-253. PubMed ID: 29240603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
    Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
    Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis.
    Wong AT; Lee YC; Schwartz D; Lee A; Shao M; Han P; Choi K; Schreiber D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1171-1177. PubMed ID: 28574930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiation followed by chemotherapy is associated with improved overall survival in endometrial cancer.
    Sinha S; Lazar A; Lam A; Anderson EM; Chen LM; Hsu IJ; Yoshida EJ
    Gynecol Oncol; 2020 Oct; 159(1):30-35. PubMed ID: 32811681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in endometrial cancer.
    Gómez-Raposo C; Merino Salvador M; Aguayo Zamora C; Casado Saenz E
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):477-486. PubMed ID: 31950214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
    Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH
    Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center.
    Tai YJ; Hsu HC; Chiang YC; Chen YL; Chen CA; Cheng WF
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.
    Goodman CR; Hatoum S; Seagle BL; Donnelly ED; Barber EL; Shahabi S; Matei DE; Strauss JB
    Gynecol Oncol; 2019 Apr; 153(1):41-48. PubMed ID: 30660345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
    Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA
    Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities.
    Nogueira-Costa G; Eiriz I; Braga S
    Cancer Treat Res Commun; 2022; 32():100581. PubMed ID: 35675758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
    Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
    Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.
    Albuquerque K; Folkert M; Mayadev J; Christie A; Liotta MR; Nagel C; Sevak P; Harkenrider MM; Lea JS; Hanna RK; Small WC; Miller DS; Xie XJ; Potkul RK; Elshaikh MA
    Am J Clin Oncol; 2018 Aug; 41(8):792-796. PubMed ID: 28225446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer.
    Jou J; Charo L; Hom-Tedla M; Coakley K; Binder P; Saenz C; Eskander RN; McHale M; Plaxe S
    Gynecol Oncol; 2021 Nov; 163(2):299-304. PubMed ID: 34561099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.